BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tobramycin

An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.

298+ PubMed studies analyzed · 42 RCTs · Evidence Score: 49.2

Research Domains

Tobramycin has been studied across 12 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🫁 Respiratory, 🫁 Liver & Detox, 😴 Sleep. The primary research focus is 🫘 Kidney with 13% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tobramycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Galactitol
2 shared targets
Carbutamide
2 shared targets
Pyrrolidonecarboxylic
2 shared targets
Leuprolide
3 shared targets
Carduus
2 shared targets
Buthionine
2 shared targets
Pyridoxine
2 shared targets
Rifaximin
4 shared targets
Tigecycline
2 shared targets
Metronidazole
2 shared targets
Loading evidence profile...

This evidence profile for Tobramycin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.